Summit Therapeutics shares surged in pre-market trading after positive clinical trial results for their cancer drug. Other notable pre-market movers include Intelligent Bio Solutions, Tonix Pharmaceuticals, and Nuburu, while Wheeler Real Estate and Golden Minerals experienced significant declines.